Browse
Submit Data
Databases
API
Help

Dataset Information

31 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer

ABSTRACT: The Personalized Discovery Process is the only program offering patients treatment recommendations based on an empirically constructed Drosophila "fly" model of their disease. Special committee selects one of the one of the few 2-3 FDA approved drug combinations or single agents that improved survival in the fly cancer model.

DISEASE(S): Medullary Thyroid Cancer,Thyroid Neoplasms,Thyroid Cancer,Colon Cancer,Colorectal Cancer,Thyroid Diseases,Colonic Neoplasms

PROVIDER: 2183852 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

E. coli, Enterococci, and Salmonella enterica

Project description:FDA CVM NARMS - EPA One Health Surface Water Study

| PRJNA884092 | ENA

Metagenome

Project description:FDA CVM NARMS - EPA One Health Surface Water Study Metagenomes

| PRJNA1177841 | ENA

Bacteria

Project description:FDA CVM NARMS - EPA One Health Watershed Surface Water Pilot

| PRJNA1186125 | ENA

Bacteria

Project description:FDA CVM NARMS - EPA One Health NRSA Surface Water Pilot

| PRJNA1186127 | ENA

Viruses

Project description:'One Health' Viral Discovery in Mammals

| PRJNA956591 | ENA

The expression signatures of circRNA in MCT-induced pulmonary arterial hypertension rat

Project description:To investigate the underlying mechanism of pulmonary hypertension, the model of monocrotaline (MCT)-treated pulmonary arterial hypertension (PAH) rats were constructed to detect the differentially expressed profile of circRNAs in lung tissue of PAH rat. The whole genome microarray expression profiling analysis as a discovery platform have been employed to identify genes difference.

2023-09-12 | GSE227339 | GEO

Investigating the expression signatures of circRNA in pulmonary arteial hypertension

Project description:To investigate the underlying mechanism of pulmonary hypertension, the model of hypoxia-treated pulmonary arterial hypertension (PAH) rats were constructed to detect the differentially expressed profile of circRNAs in lung tissue of PAH rat. The whole genome microarray expression profiling analysis as a discovery platform have been employed to identify genes difference.

2023-09-12 | GSE226952 | GEO

Gene expression markers differentiating between malignant and benign follicular thyroid tumors

Project description:Differential diagnosis between malignant follicular thyroid cancer (FTC) and benign follicular thyroid adenoma (FTA) is a great challenge for even an experienced pathologist and requires special effort. Molecular markers may potentially support a differential diagnosis between FTC and FTA in postoperative specimens. The purpose of this study was to derive molecular support for the differential diagnosis, in the form of a simple multigene mRNA-based classifier that would differentiate between FTC and FTA tissue samples.

2017-06-03 | GSE82208 | GEO

Dnase1l3 enhances antitumor immunity and suppresses tumor progression [bulk RNAseq]

Project description:For the chronic inflammation-related colon cancer model (AOM/DSS-colon cancer model), 3-month-old Dnase1l3 WT and KO mice were injected with AOM (8 mg/kg, body weight). One week later, mice were challenged with 2.5% DSS water for 7 days followed by a 14-day recovery with regular drinking water for three cycles. Body weight, rectal bleeding and diarrhea were monitored during the entire experiment. Mice with more than 25% weight loss were removed during the experiment. For the AOM model, 2-month-old Dnase1l3 WT and KO mice were injected intraperitoneally with AOM (8 mg/kg, body weight). Colon tissues were isolated 9 hours, or five days after injection. All animal experiments were conducted in accordance with guidelines of NIEHS/NIH Animal Care and Use Committee.

2022-02-07 | GSE196076 | GEO

Dnase1l3 enhances antitumor immunity and suppresses tumor progression [scRNAseq]

2022-02-07 | GSE196054 | GEO